Add like
Add dislike
Add to saved papers

Antitumoral and anticholinesterasic activity of the seven species from Rubiaceae.

BACKGROUND: The genus Psychotria and Palicourea are reported as a source of alkaloids and iridoids, which exhibit biological activities. This study aimed to evaluate the antiproliferative, anticholinesterase and LC/MS potential of the methanolic extract of seven species among the genus found in Mato Grosso do Sul region in Brazil.

METHODS: The extracts were submitted to antiproliferative activity against ten human tumor cell lines. The anticholinesterase activity of the extracts (1 mg/mL) was developed using brain structures of male Wistar rats: cerebral cortex, hippocampus, hypothalamus and striatum by the Ellman method.

RESULTS: The LC/MS was performed to identify the alkaloids present in the extracts, identifying strictosidinic acid, strictosidine, strictosamide, miriantosine, raucaffricine, calycanthine, croceaine A and B, brachycerine and bufotenine. Regarding the antiproliferative potential, Palicourea crocea demonstrated selectivity against the 786-0 cell line (GI50: 22.87 μg/mL). Psychotria leiocarpa inhibited cell growth against OVCAR-3 (GI50: 3.28 μg/mL), K-562 (GI50: 5.26 μg/mL), HaCaT (GI50: 27.20 μg/mL), PC-3 (GI50: 34.92 μg/mL), MCF-7 (GI50: 35.80 μg/mL) and P. capillacea showed activity against OVCAR-3 (GI50: 2.33 μg/ml) and U251 (GI50: 16.66 μg/ml). The effect of acetylcholinesterase inhibition was more effective in the hippocampus, demonstrating inhibition for Paliourea crocea, Psychotria deflexa, P. brachybotrya and P. leiocarpa of 70%, 57%, 50% and 40%, respectively, followed by P. poeppigiana and P. capillacea, inhibiting 21%, compared to the control.

CONCLUSION: Herein, the anticholinesterasic and antiproliferative activity of extracts produced from species of Psychotria and Palicourea genus with anticholinesterasic and antiproliferative activity is reported.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app